Taxol

7 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Observed

→ investigated in trials for

6 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Observed

Malignant Gastric Neoplasm

→ investigated in trials for

2 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Malignant Gastric Neoplasm

Observed

→ investigated in trials for

Breast Neoplasm

1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Breast Neoplasm

Observed

Malignant Cervical Neoplasm

→ investigated in trials for

1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Malignant Cervical Neoplasm

Observed

Malignant Fallopian Tube Neoplasm

→ investigated in trials for

1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Malignant Fallopian Tube Neoplasm

Observed

Malignant Head and Neck Neoplasm

→ investigated in trials for

1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Malignant Head and Neck Neoplasm

Observed

→ investigated in trials for

Malignant Lung Neoplasm

1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Malignant Lung Neoplasm

Observed

Malignant Prostate Neoplasm

→ investigated in trials for

1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Malignant Prostate Neoplasm

Observed

→ investigated in trials for

Ovarian Carcinoma

1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Ovarian Carcinoma

Observed

→ investigated in trials for

Ovarian Neoplasm

1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Ovarian Neoplasm

Observed

Primary Peritoneal Carcinoma

→ investigated in trials for

1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Primary Peritoneal Carcinoma

Observed

Taxol studied in …STUDIED_INderived10 of 23show all (up to 200)
→ studied in	NCT06839105Phase 1 · recruiting A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies · 23 trials list this drug (1 active)	—	—	Lung Non-Small Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00199758Phase 2 · completed Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer · 23 trials list this drug (1 active)	—	—	Lung Non-Small Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05636644unknown Neoadjuvant Effect of Albumin Binding Paclitaxel Compared With Common Paclitaxel in Breast Cancer：an Observational Single Center Study of Clinical Efficacy in Adjuvant Chemotherapy · 23 trials list this drug (1 active)	—	—	Malignant Breast Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT02662634Phase 2 · withdrawn A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer · 23 trials list this drug (1 active)	—	—	Lung Non-Small Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04238988Phase 2 · unknown Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer · 23 trials list this drug (1 active)	—	—	Malignant Cervical Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT00004067Phase 3 · completed Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 · 23 trials list this drug (1 active)	—	—	Malignant Breast Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT01952249Phase 1 · terminated A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian · 23 trials list this drug (1 active)	—	—	Primary Peritoneal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00394251Phase 2 · completed Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer · 23 trials list this drug (1 active)	—	—	Malignant Breast Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT00449657Phase 2 · terminated Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC · 23 trials list this drug (1 active)	—	—	Lung Non-Small Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02734524Phase 2 · unknown A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer · 23 trials list this drug (1 active)	—	—	Lung Non-Small Cell Carcinoma	1	Observed	clinicaltrials	graph →

Taxol studied in …STUDIED_INderived10 of 23show all (up to 200)

→ studied in

NCT06839105Phase 1 · recruiting

A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies · 23 trials list this drug (1 active)

—

Observed

→ studied in

NCT00199758Phase 2 · completed

Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer · 23 trials list this drug (1 active)

—

Observed

→ studied in

NCT05636644unknown

Neoadjuvant Effect of Albumin Binding Paclitaxel Compared With Common Paclitaxel in Breast Cancer：an Observational Single Center Study of Clinical Efficacy in Adjuvant Chemotherapy · 23 trials list this drug (1 active)

—

Observed

→ studied in

NCT02662634Phase 2 · withdrawn

A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer · 23 trials list this drug (1 active)

—

Observed

Malignant Cervical Neoplasm

→ studied in

NCT04238988Phase 2 · unknown

Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer · 23 trials list this drug (1 active)

—

Observed

→ studied in

NCT00004067Phase 3 · completed

Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 · 23 trials list this drug (1 active)

—

Observed

Primary Peritoneal Carcinoma

→ studied in

NCT01952249Phase 1 · terminated

A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian · 23 trials list this drug (1 active)

—

Observed

→ studied in

NCT00394251Phase 2 · completed

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer · 23 trials list this drug (1 active)

—

Observed

→ studied in

NCT00449657Phase 2 · terminated

Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC · 23 trials list this drug (1 active)

—

Observed

→ studied in

NCT02734524Phase 2 · unknown

A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer · 23 trials list this drug (1 active)

—

Observed